Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Blood
|
January 25, 2012
Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer
George Buchlis, Gregory M Podsakoff, Antonetta Radu, et al.
Molecular Therapy. Methods & Clinical Development
|
March 19, 2025
Validation of a quantitative cell-based relative potency assay for LUXTURNA
Katherine A High, Dave Le Blond, Karen Doucette, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 17, 2010
Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells
Zvi G Fridlender, Veena Kapoor, George Buchlis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 8, 2015
Crucial roles of TNFAIP8 protein in regulating apoptosis and Listeria infection
Thomas P Porturas, Honghong Sun, George Buchlis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 28, 2013
Enhanced T cell function in a mouse model of human glycosylation
George Buchlis, Pamela Odorizzi, Paula C Soto, et al.
The AAPS Journal
|
September 16, 2021
Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody Assays
Boris Gorovits, Mitra Azadeh, George Buchlis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 8, 2024
High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury
Juliette Hordeaux, R Jason Lamontagne, Chunjuan Song, et al.
Human Gene Therapy
|
May 6, 2011
Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines
Lawrence T Bish, Meg M Sleeper, Caryn Reynolds, et al.
Cancer Research
|
December 17, 2008
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy
Samuel Kim, George Buchlis, Zvi G Fridlender, et al.
Cancer Research
|
December 24, 2009
CCL2 blockade augments cancer immunotherapy
Zvi G Fridlender, George Buchlis, Veena Kapoor, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Blood
|
January 25, 2012
Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer
George Buchlis, Gregory M Podsakoff, Antonetta Radu, et al.
Molecular Therapy. Methods & Clinical Development
|
March 19, 2025
Validation of a quantitative cell-based relative potency assay for LUXTURNA
Katherine A High, Dave Le Blond, Karen Doucette, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 17, 2010
Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells
Zvi G Fridlender, Veena Kapoor, George Buchlis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 8, 2015
Crucial roles of TNFAIP8 protein in regulating apoptosis and Listeria infection
Thomas P Porturas, Honghong Sun, George Buchlis, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 28, 2013
Enhanced T cell function in a mouse model of human glycosylation
George Buchlis, Pamela Odorizzi, Paula C Soto, et al.
The AAPS Journal
|
September 16, 2021
Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody Assays
Boris Gorovits, Mitra Azadeh, George Buchlis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 8, 2024
High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury
Juliette Hordeaux, R Jason Lamontagne, Chunjuan Song, et al.
Human Gene Therapy
|
May 6, 2011
Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines
Lawrence T Bish, Meg M Sleeper, Caryn Reynolds, et al.
Cancer Research
|
December 17, 2008
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy
Samuel Kim, George Buchlis, Zvi G Fridlender, et al.
Cancer Research
|
December 24, 2009
CCL2 blockade augments cancer immunotherapy
Zvi G Fridlender, George Buchlis, Veena Kapoor, et al.
Page
of 2